ECP

Hoot Launches AI Integration on its Myopia Management Marketing Automation Platform

Retrieved on: 
Monday, July 17, 2023

PRINCETON, N.J., July 17, 2023 /PRNewswire/ -- Hoot Health, Inc., the next generation healthcare CRM, and marketing automation solution, announced today the integration of Artificial Intelligence (AI) into its Hoot Myopia Care marketing automation platform for ECPs.

Key Points: 
  • Hoot introduces new AI-generated content, video, and clinical support to empower eye care professionals (ECPs) practicing myopia management nationwide.
  • PRINCETON, N.J., July 17, 2023 /PRNewswire/ -- Hoot Health, Inc., the next generation healthcare CRM, and marketing automation solution, announced today the integration of Artificial Intelligence (AI) into its Hoot Myopia Care marketing automation platform for ECPs.
  • Hoot is pleased to take the first step towards harnessing this potential with AI-generated content, which includes educational videos and clinical briefs that complement ECPs' expertise on myopia management.
  • As a leader in marketing automation for specialty practices, Hoot's AI program will continue to expand, offering additional content and clinical decision support not only in myopia management but also in dry eye disease—a new category Hoot recently entered.

Hoot Launches Dry Eyes Marketing Automation Platform

Retrieved on: 
Wednesday, July 12, 2023

PRINCETON, N.J., July 12, 2023 /PRNewswire/ -- Hoot Health, Inc., the next generation healthcare CRM, and marketing automation solution announced today that it has launched Hoot Dry Eyes, a new marketing automation platform for Eye Care Professionals (ECPs).

Key Points: 
  • Hoot Dry Eyes.com now available to Eye Care Professionals nationwide; Dr. Todd Cohan is appointed Advisor and Medical Director, Dry Eyes.
  • PRINCETON, N.J., July 12, 2023 /PRNewswire/ -- Hoot Health, Inc., the next generation healthcare CRM, and marketing automation solution announced today that it has launched Hoot Dry Eyes, a new marketing automation platform for Eye Care Professionals (ECPs).
  • The Hoot Dry Eyes marketing automation platform allows ECPs to automate patient education, train staff through on-demand videos and simplify the entire process.
  • "As an early user of Hoot Dry Eyes, I am very excited to help more patients with dry eyes in my practice.

EyeCare Partners Introduces Advanced Comprehensive Ophthalmology Fellowship (ACOF) as Pathway to Accelerate Skill Development and Address the Need for More Trained Ophthalmologists

Retrieved on: 
Tuesday, June 27, 2023

ACOF is a one-year program that will provide comprehensive training to residency graduates in the latest advancements in ophthalmology, including diagnostic and therapeutic techniques, surgical procedures and clinical research.

Key Points: 
  • ACOF is a one-year program that will provide comprehensive training to residency graduates in the latest advancements in ophthalmology, including diagnostic and therapeutic techniques, surgical procedures and clinical research.
  • ACOF was developed by the EyeCare Partners Innovation Center, which was launched last fall to advance eye care quality, research and education.
  • “Traditional fellowships focus on subspecialities like glaucoma, cornea, anterior segment, retina, neuro-ophthalmology and oculoplastics.
  • Applications for ACOF are now open, and interested and qualified candidates are encouraged to apply at https://www.eyecare-partners.com/acof/ .

EnGenius Empowers Businesses with Safety and Controls with its New Power Distribution Line of Products

Retrieved on: 
Thursday, June 22, 2023

The PDUs boasts built-in safety features and total cloud management and control, making them essential for protecting networking and data infrastructure.

Key Points: 
  • The PDUs boasts built-in safety features and total cloud management and control, making them essential for protecting networking and data infrastructure.
  • The EnGenius ECP series are UL-1449-certified professional-grade surge protected products, placing the products through months of rigorous 3rd party testing in the lab to ensure their safety.
  • They include a Fireproof MOV module built inside to protect all plugged-in devices from power surges and spikes.
  • They also include a 15A circuit breaker to protect the PDU and everything connected to it from overcurrent and power overload.

CPKC announces Investor Day webcast

Retrieved on: 
Friday, June 16, 2023

CALGARY, AB, June 16, 2023 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) announced today that it will webcast its Investor Day presentations in Kansas City on June 28, 2023.

Key Points: 
  • CALGARY, AB, June 16, 2023 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) announced today that it will webcast its Investor Day presentations in Kansas City on June 28, 2023.
  • The live webcast and presentation slides will be available on CPKC's website at www.cpkcinvestorday.com.
  • Presentation slides will be posted on June 28 prior to the event.
  • Members of CPKC's industry-leading senior executive team will share how CPKC is primed to execute the advantages of the new combined single-line network to drive long-term profitable growth.

Tel-Instrument Electronics Corp. Reports Financial Results For Fiscal Year 2023

Retrieved on: 
Thursday, June 15, 2023

Revenues for the fiscal year ended March 31, 2023, decreased $4.3 million, or 33%, versus the prior fiscal year.

Key Points: 
  • Revenues for the fiscal year ended March 31, 2023, decreased $4.3 million, or 33%, versus the prior fiscal year.
  • Gross margin for the 2023 fiscal year was 35.3%, or 9 percentage points decline over the prior fiscal year.
  • Net loss was $389K ($-0.22 per basic share), compared to a net income of $1.3 million in the prior fiscal year.
  • Mr. Jeffrey O’Hara, Tel-Instrument’s President and CEO commented, “The 2023 fiscal year was very difficult due to parts shortages that significantly impacted production.

Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients

Retrieved on: 
Tuesday, June 13, 2023

DUBLIN, June 13, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the publication of findings from a retrospective, observational, single arm, European chart review study assessing the real-world use of extracorporeal photopheresis (ECP) and its impact on clinical outcomes in the modern era of heart transplantation.1 An online version of the data manuscript – the largest-known study of ECP in heart transplant patients – is currently published on the Journal of Heart and Lung Transplantation website in advance of print publication in the second half of 2023.

Key Points: 
  • - Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its use as a treatment for heart transplant rejection and prevention of rejection1 -
    DUBLIN, June 13, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the publication of findings from a retrospective, observational, single arm, European chart review study assessing the real-world use of extracorporeal photopheresis (ECP) and its impact on clinical outcomes in the modern era of heart transplantation.1 An online version of the data manuscript – the largest-known study of ECP in heart transplant patients – is currently published on the Journal of Heart and Lung Transplantation website in advance of print publication in the second half of 2023.
  • Interim results of this study were presented in a late-breaking session at the 20th Congress of the European Society for Organ Transplantation (ESOT) in 2021 in Milan, Italy.2
    The study, titled "European Multicenter Study on The Real-World Use and Clinical Impact of Extracorporeal Photopheresis After Heart Transplantation," examined data from the medical charts of 105 patients who received ECP following heart transplantation at seven medical centers in Austria, Germany, France, Hungary, and Italy between 2015 – 2021.
  • At time of data extraction, 58 patients (55.2%) had completed their ECP treatment and 47 patients' (44.8%) ECP treatment was ongoing.1
    "These findings from the largest European and first multicenter study investigating the real-world use of ECP in heart transplant patients support ECP as a treatment for various types of graft rejection and in prevention of graft rejection with varied treatment schedules,1" said Markus Barten, M.D., Surgical Director of Heart Failure Clinic, University Heart and Vascular Center Hamburg.
  • "This data not only builds upon the growing body of real-world evidence supporting the use of ECP in heart transplant patients, but also reflects the importance of supporting clinicians with treatment modalities for transplant rejection and stabilization.1"

Energy Capital Partners and Former GIP Credit Partners Launch ECP ForeStar Sustainable Credit Platform

Retrieved on: 
Wednesday, June 7, 2023

Energy Capital Partners (“ECP”), a leading energy transition-focused investor with a nearly two-decades-long track record of investments in the electricity, clean energy, renewable and sustainable infrastructure sectors, today announced that a team led by former Global Infrastructure Partners’ (“GIP”) partners, Jennifer Powers and Reiner Boehning, will merge into ECP’s dedicated credit investing business and launch a sustainable credit platform named ECP ForeStar, which will offer credit solutions to a broad array of businesses focused on climate transition, decarbonization and sustainable solutions.

Key Points: 
  • Energy Capital Partners (“ECP”), a leading energy transition-focused investor with a nearly two-decades-long track record of investments in the electricity, clean energy, renewable and sustainable infrastructure sectors, today announced that a team led by former Global Infrastructure Partners’ (“GIP”) partners, Jennifer Powers and Reiner Boehning, will merge into ECP’s dedicated credit investing business and launch a sustainable credit platform named ECP ForeStar, which will offer credit solutions to a broad array of businesses focused on climate transition, decarbonization and sustainable solutions.
  • The platform will significantly grow ECP’s existing credit strategy with an expanded team and over $2.5 billion in initial capital allocations.
  • At GIP, they established, grew and led the GIP Credit platform, where they managed over $5 billion of credit capital.
  • ECP ForeStar’s sustainable credit platform will be highly differentiated and be at the forefront of financing the sustainable industrial revolution, wholly focused on providing credit capital to businesses supporting decarbonization and sustainability.

HOYA Vision Care Launches 2023 'Summer Learning Series' for Eye Care Professionals

Retrieved on: 
Tuesday, May 30, 2023

LEWISVILLE, Texas, May 30, 2023 /PRNewswire/ -- Ophthalmic lens technology leader HOYA Vision Care announced today its 'Summer Learning Series' of free webinars for eye care professionals (ECP) and their practices. From June 7 through July 26, 2023, HOYA will host eight specially designed courses hosted by in-house product and training experts. ECPs can register today for individual or all the webinars.

Key Points: 
  • LEWISVILLE, Texas, May 30, 2023 /PRNewswire/ -- Ophthalmic lens technology leader HOYA Vision Care announced today its ' Summer Learning Series ' of free webinars for eye care professionals (ECP) and their practices.
  • From June 7 through July 26, 2023, HOYA will host eight specially designed courses hosted by in-house product and training experts.
  • "We are excited to continue offering independent, visionary ECPs ways to grow their skills and enhance their practices," said Matt Pope, Sr. Director of Marketing at HOYA Vision Care.
  • HOYA's Single Vision Portfolio – June 28, 2023 – 6:00 pm CDT
    Old technology, traditional single vision lenses do not meet your patients' demanding needs for overall quality vision.

BlakYaks Secures Coveted Kubernetes on Microsoft Azure Specialist Partner Certification

Retrieved on: 
Thursday, May 18, 2023

BlakYaks , a prominent cloud-native consulting, engineering, and managed service provider, has announced that it has achieved the highly sought-after Kubernetes on Microsoft Azure Specialist Partner Certification.

Key Points: 
  • BlakYaks , a prominent cloud-native consulting, engineering, and managed service provider, has announced that it has achieved the highly sought-after Kubernetes on Microsoft Azure Specialist Partner Certification.
  • BlakYaks underwent an extensive external audit process to achieve the Kubernetes on Microsoft Azure Specialist Partner Certification.
  • BlakYaks is also a Digital & App Innovation (Azure) and Infrastructure (Azure) Microsoft Solutions Partner, underscoring its deep Azure expertise and commitment to customer satisfaction.
  • BlakYaks' achievement of the Kubernetes on Microsoft Azure Specialist Partner Certification demonstrates its commitment to excellence and its dedication to providing customers with the highest quality cloud-native solutions available.